Hsbc Holdings PLC Makes New $833,000 Investment in Sotera Health Company $SHC

Hsbc Holdings PLC bought a new position in shares of Sotera Health Company (NASDAQ:SHC) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 46,892 shares of the company’s stock, valued at approximately $833,000.

Several other hedge funds have also modified their holdings of SHC. Sculptor Capital LP increased its holdings in shares of Sotera Health by 57.4% in the fourth quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after purchasing an additional 7,658,200 shares in the last quarter. Vanguard Group Inc. raised its position in Sotera Health by 16.7% in the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after purchasing an additional 2,756,583 shares during the last quarter. Sachem Head Capital Management LP lifted its holdings in Sotera Health by 47.2% during the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after buying an additional 3,735,000 shares in the last quarter. Janus Henderson Group PLC lifted its holdings in Sotera Health by 4.8% during the 4th quarter. Janus Henderson Group PLC now owns 6,772,059 shares of the company’s stock worth $119,460,000 after buying an additional 312,191 shares in the last quarter. Finally, State Street Corp boosted its position in Sotera Health by 21.0% in the 4th quarter. State Street Corp now owns 5,965,326 shares of the company’s stock valued at $105,228,000 after buying an additional 1,035,457 shares during the last quarter. 91.03% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently commented on SHC. Barclays lifted their target price on Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Wall Street Zen cut Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Piper Sandler reissued an “overweight” rating and set a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. UBS Group set a $19.00 target price on shares of Sotera Health in a research report on Wednesday, June 24th. Finally, Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Sotera Health has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Trading Down 2.1%

NASDAQ SHC opened at $17.78 on Wednesday. The stock has a 50-day simple moving average of $16.32 and a 200 day simple moving average of $16.39. The company has a market capitalization of $5.07 billion, a PE ratio of 43.37 and a beta of 1.76. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. Sotera Health Company has a 12 month low of $10.94 and a 12 month high of $19.85.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The firm had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. During the same quarter in the prior year, the firm posted $0.14 earnings per share. The company’s quarterly revenue was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Research analysts forecast that Sotera Health Company will post 0.87 EPS for the current year.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 15.36% of the stock is owned by corporate insiders.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.